Hesai Group introduced Kosmo, a 3D world data engine combining the Kosmo One AI spatial camera and Kosmo World cloud platform to create high-fidelity 3D digital environments. This innovation addresses the challenge of accessing large-scale, high-quality real-world data for Physical AI, enabling faster and more accurate robot training, world model development, and immersive content creation. Kosmo significantly reduces time and cost in applications like robotics, filmmaking, and location services, with strategic partnerships enhancing its ecosystem. Hesai aims to expand its Physical AI capabilities by integrating Kosmo with its existing lidar and robotic actuation technologies, driving growth in AI-driven real-world understanding and interaction.
Hesai's launch of the Kosmo 3D World Data Engine is the subject here, with Pluang's Technology sector market data providing context. Of 150 priced US Technology stocks on Pluang, 23 rose and 127 fell. Notable movers include CLS at USD 325.71 with a -8.88% change, BBAI at USD 2.20 with a -8.33% change, and AKAM at USD 91.79 with a -8.15% change. This data is as of Oct 14, 2026 23:21 WIB.
Jefferies has maintained a Buy rating on Big Yellow Group despite recent stock declines, citing the company's strong fundamentals including freehold properties and solid cash flows. Activist investor Ancora, holding over 4% of shares, is pushing Big ...
Fastenal reported strong Q3 2026 earnings, beating analyst expectations with EPS of $0.35 and revenue of $2.46 billion. The company saw a 20% rise in net income to $401.6 million and a 15.5% increase in revenue driven by robust manufacturing demand, ...
Remittix announced the public launch of its RTX token on November 24, 2026, marking the end of its presale phase which raised over $32 million from 40,000 participants. The project is testing its PayFi platform, which enables crypto-to-fiat and fiat-...
The global microbiology testing market is projected to grow rapidly at a compound annual growth rate (CAGR) of approximately 9% from 2026 to 2034, reaching a market size of $13.7 billion by 2034. This growth is driven by the rising prevalence of infe...
H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform ...
